Hope you can retire on this Seth, you've been a source of good info since I started trading soda 2 years ago! I have a small position today but am happy it may be getting the respect it deserves.
Per Reuters: Biogen Idec Inc expects a delay in the European launch of its multiple sclerosis drug Tecfidera as the drugmaker works to secure exclusive data that could potentially protect its treatment from generic competition for a longer period.Tecfidera, which is expected to receive European regulatory approval this quarter,
Per Bloomberg: Biogen Idec Inc. (BIIB), the world’s biggest maker of multiple sclerosis drugs, said a European regulatory decision on its new pill will be delayed until the second half of this year after a patent on the medicine was extended.
Great news! The EU approval s/b in the next few weeks!